Showpad eOS® vs mycx
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Showpad eOS®
Empower your sales team with a mobile app designed to enhance buyer interactions and accelerate deal closures. Access relevant content, deliver dynamic presentations, and gain insights into buyer engagement for more effective follow-ups.
- AI-powered content discovery
- Interactive 3D and AR presentations
- Secure buyer microsites with chat
- Seamless content sharing
- Buyer engagement analytics
- Offline content access
Read full descriptionHide full description
Showpad’s mobile app empowers sellers on the go to spark impactful conversations and close deals faster. Access the right content, deliver engaging presentations, and share effortlessly — all while unlocking insights into buyer engagement for more personalized follow-up. Key Benefits - Find the right content to engage buyers, online or offline, powered by AI - Deliver immersive presentations with interactive 3D models and augmented reality - Collaborate seamlessly with buyers through a branded, secure microsite — featuring real-time chat to keep deals moving forward - Share content seamlessly across platforms, from email to instant messaging - Get notified when buyers engage with your content, enabling faster and more personalized follow-ups
mycx
Connect with a professional community focused on vascular and lymphatic treatments. Engage in discussions about critical medical issues and share insights on various vascular conditions.
- Vascular treatment discussions
- Aortic, Peripheral, Venous & Lymphatic focus
- Vascular Access and Acute Stroke topics
- Vascular Trauma and Hurting Leg issues
- Professional community engagement
Read full descriptionHide full description
Join the CX community and get involved in the hottest Aortic, Peripheral, Venous & Lymphatic, Vascular Access, Acute Stroke, Vascular Trauma and Hurting Leg treatment issues.
Screenshots
Verdict
The clearest difference is review sentiment: Showpad eOS® at 66% against mycx's 0%. Showpad eOS® also leads on ads (none vs shown) and update cadence (every 2 weeks vs every 6 weeks). mycx's advantage is monetization model (ad-supported vs freemium). On price, in-app purchases, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Showpad eOS® ships an update every 2 weeks, mycx every 6 weeks. The most recent releases landed on October 10, 2026 and October 4, 2026 respectively.
| Parameter | Showpad eOS® | mycx |
|---|---|---|
| Price | Free | Free |
| Rating | 4.1 (29 ratings) — better | — |
| Positive reviews | 65.7% of reviews — better | 0.0% of reviews |
| Number of ratings | 29 — better | — |
| Update frequency | Every 2 weeks — better | Every 6 weeks |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Freemium | Ad-supported — better |
| Devices | iPhone, iPad — better | iPhone |
| Requires iOS | 18.4 | 17.0 — better |
| Further details — not scored | ||
| Size | 166 MB | 146 MB |
| Age rating | 4+ | 17+ |
| Developer | Showpad | BIBA Medical Ltd |
Customer experience
Showpad eOS®
mycx
In-app purchases
Showpad eOS®
No in-app purchases
mycx
No in-app purchases
